Ventures in Residence

Aldatu Biosciences

At Aldatu, we are applying our proprietary genotyping tech, PANDAA, to the development of diagnostic tools specifically designed to meet the clinical requirements and economic constraints of their intended use setting. By uniquely enabling an existing technology platform – qPCR – we bring its speed, sensitivity, and affordability to new diagnostic applications like HIV drug resistance testing.


  • Harvard Graduate School of Arts and Sciences
  • Harvard School of Public Health
  • Fall 2016
Venture Status
  • Alumni
  • Devices/Hardware
  • Global/Public Health
  • Life/Physical Sciences
  • Research Tools

Team News

Local biotech gets $3M NIH grant for HIV drug resistance test